We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Balkeet Singh Khaira sold hundreds of thousands of Class C drugs from his mother's pharmacy
The public has until 5 March to respond to the consultation on the potential reclassification of desogestrel to a pharmacy medicine.
The new vaccine has been approved after meeting the required safety, quality and effectiveness standards.
The CMA has accepted legally binding commitments from Essential Pharma to continue supplying a key bipolar drug at an affordable price for at least 5 years.
The MHRA has published advice for patients and healthcare professionals
Recent media reports have suggested that chloroquine can protect patients from coronavirus or treat COVID-19, the illness caused by a coronavirus.
The health minister's letter thanks directors of public health and their teams for their response to COVID-19 so far.
First published during the 2019 to 2022 Johnson Conservative government
Expert Working Group concludes there is currently insufficient evidence to establish a link between use of ibuprofen and susceptibility to contracting COVID-19 or the worsening of its symptoms.
The health minister's letter thanks pharmacy teams for their response to coronavirus so far.
£300 million in funding will ensure community pharmacies can continue to carry out essential services during the coronavirus (COVID-19) outbreak.
There is no evidence from clinical or epidemiological studies that treatment with ACE-I or ARBs might worsen COVID-19 infection.
Patients prescribed cannabis-based medicines will be able to get their treatment in days rather than months.
Patients who have recently been discharged from hospital will get greater support from local pharmacy teams to manage their medicines.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
MHRA investigation reveals illegally supplied opiate painkillers, tranquillisers and medications intended for the treatment of cancer worth £280,490.
People with minor illnesses or who need medicine urgently have been referred to local pharmacies, relieving pressure on doctors.
Ranitidine – MHRA drug alert issued as Creo Pharma Limited and Tillomed Laboratories recall unexpired stock
The service will help GPs and pharmacists prescribe and dispense medicines faster and more securely and make it easier for patients to pick up repeat prescriptions.
The Medicines and Healthcare products Regulatory Agency have released a Strategy for Pharmacopoeial Public Quality Standards for Biological Medicines update.
Patients with minor health issues will be offered same-day appointments at their local pharmacy, under a new deal announced by the Health and Social Care Secretary.
First published during the 2016 to 2019 May Conservative government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).